Georgios Tsakonas

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ESMO OPEN. 2026;11(1):106028
Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery
Koulouris A; Grundberg O; Skribek M; Kamali C; Hydbring P; Gubanski M; Ekman S; Tsakonas G
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2025;20(10):s184
P1.11.39 The BLIP Score: A Tool for Non-Small Cell Lung Cancer Patients With Brain Metastases
Skribek M; Livanou M-E; Vathiotis I; Strandman V; Thorell A; Koulouris A; Syrigos K; Ekman S; Tsakonas G
Article: COMPUTERS IN BIOLOGY AND MEDICINE. 2025;196(Pt B):110790
The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases.
Koulouris A; Skribek M; Kamali C; Grundberg O; Gubanski M; Kalaitzidis K; Lampa E; Hydbring P; Ekman S; Tsakonas G
Journal article: ANNALS OF ONCOLOGY. 2025;36:s489-s490
EGFR-BPI: A novel prognostic tool for EGFR-mutated NSCLC with brain metastases
Koulouris AV; Petrov I; Skribek MC; Hydbring P; Gubanski M; Ekman S; Tsakonas G
Article: JOURNAL OF THORACIC ONCOLOGY. 2025;20(8):1108-1119
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
Gronberg BH; Killingberg KT; Flotten O; Bjaanaes MM; Brustugun OT; Madebo T; Langer SW; Risumlund SL; Schytte T; Helbekkmo N; Neumann K; Yksnoy O; Engleson J; Fluge S; Naustdal T; Giske LE; Nyman J; Tsakonas G; Halvorsen TO
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(17_SUPPL):lba8005
Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC).
Aanerud M; Dumoulin DW; Nyman J; Schytte T; Bjaanaes MM; Neumann K; Tsakonas G; Kastelijn EA; Helbekkmo N; Langer SW; Rothschild S; Appenzeller C; Stigt J; Mcculloch T; Sorger H; Sandvei MS; Killingberg KT; Froseth TC; Halvorsen TO
Article: LUNG CANCER. 2025;199:108065
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers
Zerdes I; Kamali C; Johannsdottir B; Blasi M; Assmann C; Kazdal D; Stenzinger A; Skribek M; Ekman S; Christopoulos P; Tsakonas G
Article: TRANSLATIONAL LUNG CANCER RESEARCH. 2024;13(11):0
Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study
Kamali C; Tsakonas G; Hydbring P; Jatta K; Berglund A; Viktorsson K; Lewensohn R; De Petris L; Ekman S
Article: EUROPEAN JOURNAL OF RADIOLOGY. 2024;177:111557
Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar)
Grundberg O; Skribek M; Swerkersson S; Skorpil M; Kolbeck K; Grozman V; Nyren S; Tsakonas G
Article: ESMO OPEN. 2023;8(6):102069
Validation of the ALK-Brain Prognostic Index for patients with ALK- rearranged lung cancer and brain metastases
Zerdes I; Kamali C; Koulouris A; Elsayed M; Schnorbach J; Christopoulos P; Tsakonas G
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s638
EP11.03-40 An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients
Skribek M; Sierakowiak A; Koulouris A; Rounis K; Goenechea J; Labor M; Lund HW; Axelsson I; Fornwall A; Tsakonas G; Koyi H
Article: LUNG CANCER. 2023;182:107292
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_SUPPL):8512
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Gronberg BHH; Killingberg KT; Flotten O; Bjaanaes MM; Madebo T; Schytte T; Langer SW; Risumlund SL; Helbekkmo N; Neumann K; Brustugun OT; Yksnoy O; Tsakonas G; Engleson J; Fluge S; Naustdal T; Giske LE; Nyman J; Halvorsen TO
Article: PLOS ONE. 2023;18(2):e0277708
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
Makrakis D; Rounis K; Tsigkas A-P; Georgiou A; Galanakis N; Tsakonas G; Ekman S; Papadaki C; Monastirioti A; Kontogianni M; Gioulbasanis I; Mavroudis D; Agelaki S
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;24(1):193
Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
Tsakonas G; Koulouris A; Kazmierczak D; Botling J; Ortiz-Villalon C; Nord H; Lindskog M; Sandelin M; Micke P; Hydbring P; Ekman S
Article: TRANSLATIONAL LUNG CANCER RESEARCH. 2022;11(10):2064-2078
Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients
Alexeyenko A; Brustugun OT; Eide IJZ; Gencheva R; Kosibaty Z; Lai Y; de Petris L; Tsakonas G; Grundberg O; Franzen B; Viktorsson K; Lewensohn R; Hydbring P; Ekman S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):s156
P2.13-03 Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer
Alexeyenko A; Brustugun OT; Eide IJZ; Gencheva R; Kosibaty Z; Lai Y; de Petris L; Tsakonas G; Grundberg O; Franzen B; Viktorsson K; Lewensohn R; Hydbring P; Ekman S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):s574
EP16.02-008 Cerebrospinal Fluid as a Liquid Biopsy for Molecular Characterization of Brain Metastases in Patients With Non-small Cell Lung Cancer
Tsakonas G; Tadigotla V; Chakrabortty S; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Article: CANCERS. 2022;14(14):3430
Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer
Kosibaty Z; Brustugun OT; Eide IJZ; Tsakonas G; Grundberg O; De Petris L; McGowan M; Hydbring P; Ekman S
Article: TRANSLATIONAL LUNG CANCER RESEARCH. 2022;11(5):722-734
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer
Kazmierczak D; Eide IJZ; Gencheva R; Lai Y; Lewensohn R; Tsakonas G; Grundberg O; de Petris L; McGowan M; Brustugun OT; Ekman S; Hydbring P
Visa fler

Alla övriga publikationer

Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2025;20(10)
The BLIP Score: A Tool for Non-Small Cell Lung Cancer Patients With Brain Metastases
Skribek M; Livanou M-E; Vathiotis I; Strandman V; Thorell A; Koulouris A; Syrigos K; Ekman S; Tsakonas G
Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(16_SUPPL):2024
Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery.
Koulouris A; Grundberg O; Skribek M; Kamali C; Gubanski M; Ekman S; Tsakonas G
Preprint: MEDRXIV. 2024
The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain Metastases
Skribek M; Livanou M-E; Vathiotis I; Strandman V; Thorell A; Koulouris A; Syrigos K; Ekman S; Tsakonas G
Meeting abstract: ANNALS OF ONCOLOGY. 2024;35:s858
The Stereotactic Radiosurgery-Brain Prognostic Index (SRS-BPI): A novel prognostic index for lung cancer patients with brain metastases eligible for SRS
Koulouris AV; Skribek MC; Kamali C; Grundberg O; Lampa E; Gubanski M; Hydbring P; Ekman S; Tsakonas G
Review: INTERNATIONAL JOURNAL OF CANCER. 2023;153(9):1556-1567
Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis
Tsakonas G; Ekman S; Koulouris A; Adderley H; Ackermann CJ; Califano R
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s599
EP09.04-01 Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
Tsakonas G; Skribek M; Kamali C; Zerdes I; Jóhannsdóttir B; Ekman S
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s647
EP12.01-18 Validation of the ALK-Brain Prognostic Index (ALK-BPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases
Tsakonas G; Kamali C; Zerdes I; Koulouris A; Hydbring P; Christopoulos P
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S647
Validation of the ALK-Brain Prognostic Index (ALKBPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases
Tsakonas G; Kamali C; Zerdes I; Koulouris A; Hydbring P; Christopoulos P
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S599
Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
Tsakonas G; Skribek M; Kamali C; Zerdes I; Johannsdottir B; Ekman S
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S638
An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients
Skribek M; Sierakowiak A; Koulouris A; Rounis K; Goenechea J; Labor M; Lund HW; Axelsson I; Fornwall A; Tsakonas G; Koyi H
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC)
Gronberg BHH; Killingberg KT; Flotten O; Bjaanaes MM; Madebo T; Schytte T; Langer SW; Risumlund SL; Helbekkmo N; Neumann K; Brustugun OT; Yksnoy O; Tsakonas G; Engleson J; Fluge S; Naustdal T; Giske LE; Nyman J; Halvorsen TO
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):S156
Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer
Alexeyenko A; Brustugun OT; Eide IJZ; Gencheva R; Kosibaty Z; Lai Y; de Petris L; Tsakonas G; Grundberg O; Franzen B; Viktorsson K; Lewensohn R; Hydbring P; Ekman S
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):S574
Cerebrospinal Fluid as a Liquid Biopsy for Molecular Characterization of Brain Metastases in Patients With Non-small Cell Lung Cancer
Tsakonas G; Tadigotla V; Chakrabortty S; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Review: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):732-754
Complications following novel therapies for non-small cell lung cancer
Skribek M; Rounis K; Tsakonas G; Ekman S
Conference publication: ANNALS OF ONCOLOGY. 2021;32:S1006
Effect of fat tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
Rounis K; Makrakis D; Tsigkas A-P; Georgiou A; Galanakis N; Tsakonas G; Papadaki C; Monastirioti A; Kontogianni M; Gioulbasanis I; Mavroudis D; Agelaki S
Review: CLINICAL RHEUMATOLOGY. 2021;40(5):1687-1695
Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?
Chatzidionysiou K; Liapi M; Tsakonas G; Gunnarsson I; Catrina A
Doctoral thesis: 2020
Biomarkers for CNS metastasis in non-small cell lung cancer (NSCLC)
Tsakonas G
Review: EUROPEAN JOURNAL OF CANCER. 2020;125:1-11
Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations?
Califano R; Gomes F; Ackermann CJ; Rafee S; Tsakonas G; Ekman S
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2019;14(10):S654
Gene Expression Profiling of CNS Metastases in Non-Small Cell Lung Cancer - Matched Analyses with Primary Tumors
Tsakonas G; Hydbring P; Ekman S
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2018;13(10):S976
A Retrospective Study Examining the Role of PET-CT in the 8th TNM Staging System of SCLC
Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L
Visa fler

Anställningar

Postdoktorala Studier, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, onkologi, Karolinska Institutet, 2025
Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2020

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI